Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-04

Clinical Trial Update: Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]

View source ↗

Summary

This Phase 2 safety study evaluating danazol in combination with plasma exchange and steroids for thrombotic thrombocytopenic purpura was terminated; results ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Danazol (danazol)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Thrombotic Thrombocytopenic Purpura | Phase 2 | Status: TERMINATED | Results posted: 2023-08-04